Private Advisor Group LLC increased its stake in shares of abrdn Healthcare Investors (NYSE:HQH - Free Report) by 50.3% during the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 52,130 shares of the financial services provider's stock after acquiring an additional 17,448 shares during the period. Private Advisor Group LLC owned approximately 0.10% of abrdn Healthcare Investors worth $847,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently bought and sold shares of HQH. Prevail Innovative Wealth Advisors LLC raised its position in shares of abrdn Healthcare Investors by 69.6% in the 1st quarter. Prevail Innovative Wealth Advisors LLC now owns 62,394 shares of the financial services provider's stock valued at $1,013,000 after purchasing an additional 25,607 shares in the last quarter. WESPAC Advisors LLC acquired a new position in shares of abrdn Healthcare Investors in the 1st quarter valued at approximately $399,000. Moloney Securities Asset Management LLC raised its position in shares of abrdn Healthcare Investors by 49.1% in the 1st quarter. Moloney Securities Asset Management LLC now owns 16,324 shares of the financial services provider's stock valued at $265,000 after purchasing an additional 5,379 shares in the last quarter. Envestnet Asset Management Inc. acquired a new position in shares of abrdn Healthcare Investors in the 1st quarter valued at approximately $426,000. Finally, Penserra Capital Management LLC raised its position in shares of abrdn Healthcare Investors by 8.5% in the 1st quarter. Penserra Capital Management LLC now owns 1,008,526 shares of the financial services provider's stock valued at $16,378,000 after purchasing an additional 78,771 shares in the last quarter. 32.60% of the stock is owned by institutional investors and hedge funds.
abrdn Healthcare Investors Stock Performance
Shares of HQH traded up $0.09 during trading on Friday, reaching $15.74. The company's stock had a trading volume of 74,192 shares, compared to its average volume of 213,160. abrdn Healthcare Investors has a twelve month low of $13.77 and a twelve month high of $19.79. The company has a fifty day moving average of $15.65 and a two-hundred day moving average of $16.20.
abrdn Healthcare Investors Increases Dividend
The company also recently declared a quarterly dividend, which was paid on Monday, June 30th. Stockholders of record on Thursday, May 22nd were issued a $0.54 dividend. This is a positive change from abrdn Healthcare Investors's previous quarterly dividend of $0.50. The ex-dividend date was Thursday, May 22nd. This represents a $2.16 dividend on an annualized basis and a dividend yield of 13.7%.
abrdn Healthcare Investors Company Profile
(
Free Report)
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries.
Read More

Before you consider abrdn Healthcare Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and abrdn Healthcare Investors wasn't on the list.
While abrdn Healthcare Investors currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.